A randomized controlled study of iron supplementation in patients treated with erythropoietin
about
Parenteral versus oral iron therapy for adults and children with chronic kidney diseaseSafety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trialsMechanisms of anemia in CKD.Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron statusClinical Translation of Nanomedicine.Ferric citrate controls phosphorus and delivers iron in patients on dialysis.Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate.The pathological consequences of anaemia.Intravenous iron exposure and mortality in patients on hemodialysisSerum iron markers are inadequate for guiding iron repletion in chronic kidney diseaseA randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.Anaemia in kidney disease: harnessing hypoxia responses for therapyA randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trialThe role of intravenous iron in the treatment of anemia in cancer patientsFerric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.Intravenous iron dextran as a component of anemia management in chronic kidney disease: a report of safety and efficacy.Beyond efficacy and safety-the need for convenient and cost-effective iron therapy in health careRoxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsAngina pectoris and intensive intravenous iron treatment in hemodialysis patients.Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis.A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.Safety issues with intravenous iron products in the management of anemia in chronic kidney diseasePrevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study.Managing anemia in lymphoma and multiple myelomaAnemia of critical illness.The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.Iron deficiency anemia in heart failure.Iron toxicity: relevance for dialysis patients.Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency.Heme iron polypeptide for the management of anaemia of chronic kidney disease.Effects of iron supplementation on erythropoietic response in patients with cancer-associated anemia treated by means of erythropoietic stimulating agents.Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis.
P2860
Q24203895-E68E925B-DD74-4CFB-96C3-A8DCD007DF7DQ26829377-9E81FAC8-A6E2-452F-8B58-12E47A162C24Q27693202-1C5EC1E2-4664-46FE-AD95-E10F348F446AQ28648176-A205065B-87DE-4037-A403-1D8F1A9DEBCDQ30355939-A6D28BD5-84F6-4029-95F6-3A4A25F6561CQ30361082-03A0CE48-4C98-4957-B1FF-7C6E09509AD6Q32035364-E6B41863-8401-4D64-B70D-681C8444DFA5Q33999246-42BEBE17-1EEF-4F0B-8215-AEAE3D663E99Q34041146-7F8E4E13-7C55-40AC-8C8B-FC8EB5CDEE43Q34113833-E5E4CD57-2A72-452B-BE2B-0B6D3BA9B798Q34291421-AE18A2AB-B47F-4D7F-B22A-8C5054A63C4AQ34455198-7D1C2BB1-2AF3-4E20-BE31-48E8AAB31928Q34497292-ED3CF823-99E4-4890-BC58-ECC2717F407AQ34885195-7E863ABA-C28F-4249-8A73-CE0CCA6B3396Q35836904-AF2752B1-0828-473F-A31B-662B74C2ADFCQ35998091-C380C96E-FCCD-4677-97D8-5B455BC48767Q36104846-08ACBD12-FF0F-4398-9141-C666640FB52FQ36251928-6C3BE585-3E80-4C51-86F9-9029C1A05DBBQ36612686-15BEFEF8-9174-4BDD-8F36-2C61FF39784DQ36677375-99FAD7F6-6233-492C-9318-4FCEFF1AA08CQ36734021-65C2491F-4221-449B-BBE7-28AD706EBAFCQ36745330-771C5C4E-DEE7-4B69-B280-30141A6440FDQ36746098-3569D105-EAB2-44FC-A6C8-F9EA68B70063Q36765940-258D1B9E-555B-4A8C-A2C0-75F482DBEA73Q36946004-DCBA5079-27DF-410B-A1E0-FC80DAD3406AQ37000231-2F31D031-6924-4D92-982A-4A765BB4670DQ37087894-3CDF7D4C-1CEF-49F6-B2E4-A0C43A5F696FQ37161960-2A126422-5FF6-4842-B512-C42B7A305BA7Q37205657-A9FE93EB-9C97-4ADD-9113-D5E50D6ACA3DQ37252771-A61EB09E-F277-4494-B0F4-B80D4A14CF4AQ37281589-A9D684EC-1073-471E-B527-B496ED16E448Q37542851-E674121E-593E-44B3-8BC2-3825DEA6BADBQ37883005-7D08505B-19AB-416B-879B-C17E80E706DCQ37980044-AB96CC06-8496-4F78-A615-D04CBB8B6BB4Q38040656-56977E14-DB31-4A01-9A3F-EC925312FBFBQ38156094-3AAB4FB4-2061-4B92-97CC-6B22F6408DBCQ38374099-295526DB-A640-4ACB-8B67-C848C51254CFQ38466363-DFCA93F0-D5D9-49CA-872D-C53647A14277Q38755414-0BB8B681-19B5-40ED-AD3C-0E4DAB6F9C43Q38971743-155BD6F3-C8CB-4D02-8321-6882448B9AC9
P2860
A randomized controlled study of iron supplementation in patients treated with erythropoietin
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A randomized controlled study ...... ts treated with erythropoietin
@ast
A randomized controlled study ...... ts treated with erythropoietin
@en
A randomized controlled study ...... ts treated with erythropoietin
@nl
type
label
A randomized controlled study ...... ts treated with erythropoietin
@ast
A randomized controlled study ...... ts treated with erythropoietin
@en
A randomized controlled study ...... ts treated with erythropoietin
@nl
prefLabel
A randomized controlled study ...... ts treated with erythropoietin
@ast
A randomized controlled study ...... ts treated with erythropoietin
@en
A randomized controlled study ...... ts treated with erythropoietin
@nl
P2093
P3181
P356
P1433
P1476
A randomized controlled study ...... ts treated with erythropoietin
@en
P2093
C R Tomson
I C Macdougall
J Thompson
P2888
P304
P3181
P356
10.1038/KI.1996.487
P407
P577
1996-11-01T00:00:00Z
P5875
P6179
1045294376